• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Abbott RealTime 检测法的改良,可检测每毫升血浆 RNA 病毒载量低于 1 拷贝的 HIV-1。

Modification of the Abbott RealTime assay for detection of HIV-1 plasma RNA viral loads less than one copy per milliliter.

机构信息

San Francisco VA Medical Center, San Francisco, CA 94121, USA.

出版信息

J Virol Methods. 2011 Aug;175(2):261-5. doi: 10.1016/j.jviromet.2011.04.015. Epub 2011 Apr 22.

DOI:10.1016/j.jviromet.2011.04.015
PMID:21536073
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3827908/
Abstract

Although commercial tests are approved for detection of HIV-1 plasma viral loads ≥ 20 copies per milliliter (ml), only one specialized research assay has been reported to detect plasma viral loads as low as 1 copy/ml. This manuscript describes a method of concentrating HIV-1 virions from up to 30 ml of plasma, which can be combined with a commercial viral load test to create a widely available, reproducible assay for quantifying plasma HIV RNA levels less than 1 copy/ml. Using this pre-analytically modified assay, samples with a known level of 0.5 copy/ml were detected in 8 of 12 replicates (mean 0.47 copy/ml; 95% confidence interval (CI) 0.14-0.81 copy/ml) and samples with a known level of 1.0 copy/ml were detected in 13 of 13 replicates (mean 1.96 copy/ml; 95% CI 1.42-2.50 copy/ml). By concentrating virus from 30 ml of plasma, HIV RNA could be measured in 16 of 19 samples (84%) from 12 of 12 subjects (mean 2.77 copy/ml; 95% CI 0.86-4.68 copy/ml). The measured viral load correlated inversely (r = -0.78; p = 0.028) with the total duration of viral suppression (viral load<40 copies/ml).

摘要

虽然商业检测已被批准用于检测血浆中 HIV-1 病毒载量≥20 拷贝/毫升(ml),但仅有一项专门的研究检测方法可检测低至 1 拷贝/ml 的血浆病毒载量。本文描述了一种从多达 30 毫升血浆中浓缩 HIV-1 病毒粒子的方法,该方法可与商业病毒载量检测相结合,创建一种广泛可用且可重复的检测方法,用于定量检测低于 1 拷贝/ml 的血浆 HIV RNA 水平。使用这种预分析修改的检测方法,在 12 个重复实验中的 8 个(平均 0.47 拷贝/ml;95%置信区间[CI] 0.14-0.81 拷贝/ml)中检测到已知水平为 0.5 拷贝/ml 的样本,在 13 个重复实验中的 13 个(平均 1.96 拷贝/ml;95%CI 1.42-2.50 拷贝/ml)中检测到已知水平为 1.0 拷贝/ml 的样本。通过浓缩来自 30 毫升血浆的病毒,可在 12 名患者中的 11 名(16/19 样本;84%)的 19 个样本(平均 2.77 拷贝/ml;95%CI 0.86-4.68 拷贝/ml)中测量 HIV RNA。测量的病毒载量与病毒抑制的总持续时间呈负相关(r = -0.78;p = 0.028)。

相似文献

1
Modification of the Abbott RealTime assay for detection of HIV-1 plasma RNA viral loads less than one copy per milliliter. Abbott RealTime 检测法的改良,可检测每毫升血浆 RNA 病毒载量低于 1 拷贝的 HIV-1。
J Virol Methods. 2011 Aug;175(2):261-5. doi: 10.1016/j.jviromet.2011.04.015. Epub 2011 Apr 22.
2
Ability of two commercially available assays (Abbott RealTime HIV-1 and Roche Cobas AmpliPrep/Cobas TaqMan HIV-1 Version 2.0) to quantify low HIV-1 RNA Levels (<1,000 copies/milliliter): comparison with clinical samples and NIBSC working reagent for nucleic acid testing assays.两种市售检测方法(雅培实时HIV-1检测法和罗氏Cobas AmpliPrep/Cobas TaqMan HIV-1 2.0版检测法)定量检测低水平HIV-1 RNA(<1,000拷贝/毫升)的能力:与临床样本及用于核酸检测的NIBSC工作试剂的比较
J Clin Microbiol. 2014 Jun;52(6):2019-26. doi: 10.1128/JCM.00288-14. Epub 2014 Mar 26.
3
HIV-1 viral load measurement in venous blood and fingerprick blood using Abbott RealTime HIV-1 DBS assay.使用 Abbott RealTime HIV-1 DBS 检测法检测静脉血和指尖血中的 HIV-1 病毒载量。
J Clin Virol. 2017 Jul;92:56-61. doi: 10.1016/j.jcv.2017.05.002. Epub 2017 May 13.
4
Comparative evaluation of the performance of the Abbott RealTime HIV-1 assay for measurement of HIV-1 plasma viral load on genetically diverse samples from Greece.比较评估雅培实时 HIV-1 检测法在测量来自希腊的遗传多样性样本中的 HIV-1 血浆病毒载量方面的性能。
Virol J. 2011 Jan 11;8:10. doi: 10.1186/1743-422X-8-10.
5
Evaluation of the RealTime HIV-1, Xpert HIV-1, and Aptima HIV-1 Quant Dx Assays in Comparison to the NucliSens EasyQ HIV-1 v2.0 Assay for Quantification of HIV-1 Viral Load.将实时HIV-1检测、Xpert HIV-1检测和Aptima HIV-1定量Dx检测与NucliSens EasyQ HIV-1 v2.0检测进行比较以定量HIV-1病毒载量的评估。
J Clin Microbiol. 2015 Nov;53(11):3458-65. doi: 10.1128/JCM.01806-15. Epub 2015 Aug 19.
6
Significant impact of non-B HIV-1 variants genetic diversity in Gabon on plasma HIV-1 RNA quantitation.在加蓬,非 B 型 HIV-1 变体遗传多样性对血浆 HIV-1 RNA 定量有显著影响。
J Med Virol. 2014 Jan;86(1):52-7. doi: 10.1002/jmv.23770. Epub 2013 Oct 11.
7
Correlation between human immunodeficiency virus type 1 (HIV-1) RNA measurements obtained with dried blood spots and those obtained with plasma by use of Nuclisens EasyQ HIV-1 and Abbott RealTime HIV load tests.使用干血斑通过Nuclisens EasyQ HIV-1检测法和雅培实时HIV载量检测法获得的1型人类免疫缺陷病毒(HIV-1)RNA测量值与使用血浆获得的测量值之间的相关性。
J Clin Microbiol. 2009 Apr;47(4):1031-6. doi: 10.1128/JCM.02099-08. Epub 2009 Feb 4.
8
Evaluation of Performance Characteristics of the Aptima HIV-1 Quant Dx Assay for Detection and Quantitation of Human Immunodeficiency Virus Type 1 in Plasma and Cervicovaginal Lavage Samples.评估Aptima HIV-1定量诊断检测法在血浆和宫颈阴道灌洗样本中检测和定量人类免疫缺陷病毒1型的性能特征
J Clin Microbiol. 2016 Apr;54(4):1036-41. doi: 10.1128/JCM.03289-15. Epub 2016 Feb 3.
9
Comparison of HIV-1 RNA measurements obtained by using plasma and dried blood spots in the automated abbott real-time viral load assay.使用自动雅培实时病毒载量测定法,比较血浆和干血斑样本中 HIV-1 RNA 的测量值。
J Clin Microbiol. 2012 Mar;50(3):569-72. doi: 10.1128/JCM.00418-11. Epub 2011 Dec 14.
10
Comparison of Three Different FDA-Approved Plasma HIV-1 RNA Assay Platforms Confirms the Virologic Failure Endpoint of 200 Copies per Milliliter Despite Improved Assay Sensitivity.三种不同的经美国食品药品监督管理局(FDA)批准的血浆HIV-1 RNA检测平台的比较证实,尽管检测灵敏度有所提高,但每毫升200拷贝的病毒学失败终点依然成立。
J Clin Microbiol. 2015 Aug;53(8):2659-66. doi: 10.1128/JCM.00801-15. Epub 2015 Jun 10.

引用本文的文献

1
The Alphabet Soup of HIV Reservoir Markers.艾滋病病毒储存库标志物的字母组合难题
Curr HIV/AIDS Rep. 2017 Apr;14(2):72-81. doi: 10.1007/s11904-017-0355-y.
2
Exogenous and endogenous hyaluronic acid reduces HIV infection of CD4(+) T cells.外源性和内源性透明质酸可降低CD4(+) T细胞的HIV感染率。
Immunol Cell Biol. 2014 Oct;92(9):770-80. doi: 10.1038/icb.2014.50. Epub 2014 Jun 24.
3
Comparative performances of HIV-1 RNA load assays at low viral load levels: results of an international collaboration.HIV-1 RNA 载量检测在低病毒载量水平下的比较性能:国际合作的结果。

本文引用的文献

1
Differences in HIV burden and immune activation within the gut of HIV-positive patients receiving suppressive antiretroviral therapy.在接受抑制性抗逆转录病毒治疗的 HIV 阳性患者的肠道内,HIV 负担和免疫激活存在差异。
J Infect Dis. 2010 Nov 15;202(10):1553-61. doi: 10.1086/656722. Epub 2010 Oct 12.
2
The effect of raltegravir intensification on low-level residual viremia in HIV-infected patients on antiretroviral therapy: a randomized controlled trial.拉替拉韦强化治疗对接受抗逆转录病毒治疗的 HIV 感染患者低水平残留病毒血症的影响:一项随机对照试验。
PLoS Med. 2010 Aug 10;7(8):e1000321. doi: 10.1371/journal.pmed.1000321.
3
Evidence of persistent low-level viremia in long-term HAART-suppressed, HIV-infected individuals.
J Clin Microbiol. 2014 Feb;52(2):517-23. doi: 10.1128/JCM.02461-13. Epub 2013 Dec 4.
4
Challenges in detecting HIV persistence during potentially curative interventions: a study of the Berlin patient.在可能治愈的干预措施期间检测 HIV 持续存在的挑战:柏林患者研究。
PLoS Pathog. 2013;9(5):e1003347. doi: 10.1371/journal.ppat.1003347. Epub 2013 May 9.
5
HIV-1 low-level viraemia assessed with 3 commercial real-time PCR assays show high variability.用 3 种商业实时 PCR 检测法评估 HIV-1 低水平病毒血症显示出高度的变异性。
BMC Infect Dis. 2012 Apr 24;12:100. doi: 10.1186/1471-2334-12-100.
长期接受高效抗逆转录病毒治疗(HAART)抑制、HIV 感染个体中持续性低水平病毒血症的证据。
AIDS. 2010 Oct 23;24(16):2535-9. doi: 10.1097/QAD.0b013e32833dba03.
4
HIV persistence and the prospect of long-term drug-free remissions for HIV-infected individuals.HIV 持续存在以及 HIV 感染者实现长期无药物缓解的前景。
Science. 2010 Jul 9;329(5988):174-80. doi: 10.1126/science.1191047.
5
Performance evaluation of the new Roche Cobas AmpliPrep/Cobas TaqMan HIV-1 test version 2.0 for quantification of human immunodeficiency virus type 1 RNA.新罗氏 Cobas AmpliPrep/Cobas TaqMan HIV-1 试验版本 2.0 用于定量检测人类免疫缺陷病毒 1 型 RNA 的性能评估。
J Clin Microbiol. 2010 Apr;48(4):1195-200. doi: 10.1128/JCM.01832-09. Epub 2010 Feb 17.
6
HIV-1 residual viremia correlates with persistent T-cell activation in poor immunological responders to combination antiretroviral therapy.HIV-1 残余病毒血症与联合抗逆转录病毒治疗后免疫反应不佳者持续的 T 细胞活化相关。
PLoS One. 2009 Oct 30;4(10):e7658. doi: 10.1371/journal.pone.0007658.
7
The challenge of finding a cure for HIV infection.寻找治愈艾滋病毒感染方法的挑战。
Science. 2009 Mar 6;323(5919):1304-7. doi: 10.1126/science.1165706.
8
Residual viraemia in HIV-1-infected patients with plasma viral load <or=20 copies/ml is associated with increased blood levels of soluble immune activation markers.血浆病毒载量≤20拷贝/毫升的HIV-1感染患者的残余病毒血症与可溶性免疫激活标志物的血液水平升高有关。
Scand J Immunol. 2008 Dec;68(6):652-60. doi: 10.1111/j.1365-3083.2008.02184.x.
9
Biphasic decay kinetics suggest progressive slowing in turnover of latently HIV-1 infected cells during antiretroviral therapy.双相衰减动力学表明,在抗逆转录病毒治疗期间,潜伏感染HIV-1的细胞周转逐渐减慢。
Retrovirology. 2008 Nov 26;5:107. doi: 10.1186/1742-4690-5-107.
10
Evidence for persistent low-level viremia in individuals who control human immunodeficiency virus in the absence of antiretroviral therapy.在未接受抗逆转录病毒治疗的情况下控制人类免疫缺陷病毒的个体中存在持续性低水平病毒血症的证据。
J Virol. 2009 Jan;83(1):329-35. doi: 10.1128/JVI.01763-08. Epub 2008 Oct 22.